Related Experiment Video
Updated: Aug 26, 2025

Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts
Published on: March 18, 2016
Lycopene ameliorates skin aging by regulating the insulin resistance pathway and activating SIRT1
Jing Li1,2, Xin Zeng3,2, Xiaolong Yang1
1School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, P. R. China. yxl19830915@163.com.
Abstract:
Microvascular loss is one of the most important characteristics of skin aging and several microvascular activities play key roles in preserving skin health. In vitro, lycopene (Ly) reduced the contents of reactive oxygen species (ROS), β-galactosidase, and advanced glycosylation end products (AGEs), while increasing the contents of ATP and NAD+/NADH along with the mitochondrial membrane potential (MMP). Furthermore, the expression of Fibrillin-I and VEGF was increased in aged primary skin fibroblast cells (PRSFs). LC-MS non-targeted cell metabolomics demonstrated a mechanism by which (Ly) lycopene protects aging skin cells, and the KEGG analysis predicted the pathways involved. In vivo, aged rats exhibited signs of reduced capillary density and blood flow, skin aging, mitochondrial disorder, and insulin resistance. Following Ly intervention, these phenomena were reversed. Meanwhile, insulin pathway protein, VEGF, and SIRT1 protein expression data showed that lycopene might reverse insulin resistance and promote microvascular renewal to protect aging skin. In summary, all data demonstrated that Ly might reverse insulin resistance via SIRT1 during skin aging and promote microvascular neovascularization to protect aging skin.
Insights
Lycopene (Ly) reverses skin aging by improving microvascular health and combating insulin resistance. This antioxidant promotes cell repair and blood vessel regeneration, protecting aging skin.
Area of Science:
- Dermatology
- Gerontology
- Biochemistry
Background:
- Skin aging is characterized by microvascular loss, impacting skin health.
- Microvascular dysfunction and insulin resistance are key features of aged skin.
Purpose of the Study:
- To investigate the effects of lycopene on skin aging, focusing on microvascular renewal and insulin resistance.
- To elucidate the underlying mechanisms of lycopene's protective effects on aging skin cells and tissues.
Main Methods:
- In vitro studies using aged primary skin fibroblast cells (PRSFs) treated with lycopene.
- In vivo studies involving aged rats subjected to lycopene intervention.
- Analysis included reactive oxygen species (ROS), ATP, NAD+/NADH, mitochondrial membrane potential (MMP), Fibrillin-I, VEGF, insulin pathway proteins, and SIRT1 expression.
- Metabolomic analysis (LC-MS) and KEGG pathway analysis were employed.
Main Results:
- Lycopene reduced oxidative stress (ROS), senescence markers (β-galactosidase, AGEs), and improved mitochondrial function (ATP, NAD+/NADH, MMP) in vitro.
- Lycopene increased Fibrillin-I and VEGF expression in aged skin cells.
- In vivo, lycopene reversed reduced capillary density, blood flow, and signs of skin aging and mitochondrial disorder in aged rats.
- Lycopene intervention improved insulin sensitivity and upregulated VEGF and SIRT1 expression.
Conclusions:
- Lycopene effectively protects aging skin by promoting microvascular neovascularization.
- Lycopene may reverse insulin resistance via the SIRT1 pathway during skin aging.
- The findings highlight lycopene's potential as a therapeutic agent for age-related skin conditions.
More Related Videos
07:32Human Ex vivo Wound Model and Whole-Mount Staining Approach to Accurately Evaluate Skin Repair
Published on: February 17, 2021
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitochondria
Insulin: The Receptor and Signaling Pathways
iPS Cell Differentiation
PI3K/mTOR/AKT Signaling Pathway